Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.60% Nasdaq Up0.47%

Edwards Lifesciences Corp. (EW)

-NYQ

66.29 Up 0.29(0.43%) 11:14AM EDT - Nasdaq Real Time Price

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income 293,200   236,700   218,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation57,300  58,000  56,500  
Adjustments To Net Income11,800  49,500  (22,000)
Changes In Accounts Receivables(26,500)(53,700)(34,200)
Changes In Liabilities41,900  61,700  63,600  
Changes In Inventories(21,700)(57,000)(36,800)
Changes In Other Operating Activities17,800  19,300  6,300  
Total Cash Flow From Operating Activities 373,800   314,500   251,400  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(120,700)(82,900)(61,800)
Investments69,900  (283,500)(5,100)
Other Cash flows from Investing Activities(39,700)(46,400)5,400  
Total Cash Flows From Investing Activities (90,500) (412,800) (61,500)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock(244,000)(243,900)(107,900)
Net Borrowings39,500  104,400  (48,400)
Other Cash Flows from Financing Activities1,500  (1,700)(2,700)
Total Cash Flows From Financing Activities (155,600) (135,200) (103,900)
Effect Of Exchange Rate Changes12,000  8,600  (24,000)
Change In Cash and Cash Equivalents 139,700   (224,900) 62,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.